tert-Butyl 3-(cyclopropylamino)pyrrolidine-1-carboxylate

Catalog No. :
ACTJIL114
CAS No. :
887587-25-9
Molecular Formula :
C12H22N2O2
Molecular Weight :
226.32

IUPAC Name:tert-Butyl 3-(cyclopropylamino)pyrrolidine-1-carboxylate

tert-Butyl 3-(cyclopropylamino)pyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$69.00Login to see priceIn stockIn stock
1g98%$159.00Login to see priceIn stockIn stock
5g98%$490.00Login to see priceIn stockIn stock
25g98%$1960.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(cyclopropylamino)pyrrolidine-1-carboxylate
IUPAC Nametert-Butyl 3-(cyclopropylamino)pyrrolidine-1-carboxylate
MDL No.T195605
Molecular FormulaC12H22N2O2
Molecular Weight226.32
SMILESCC(C)(C)OC(=O)N1CCC(C1)NC1CC1
InChI KeyKYEGQEQHIFRJSY-UHFFFAOYSA-N
Synonym887587-25-9 | tert-Butyl 3-(cyclopropylamino)pyrrolidine-1-carboxylate | 1-BOC-3-(CYCLOPROPYLAMINO)-PYRROLIDINE | 3-Cyclopropylamino-pyrrolidine-1-carboxylic acid tert-butyl ester | 3-cyclopropylamino-pyrrolidine-1-carboxylic acid tert butyl ester | (S)-tert-Butyl
CAS No.887587-25-9
PubChem CID53346608

Synthetic Route by SureRoute

1. ACTJIL114 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0 In Stock
  4. Then
  5. ACTJIL114 route product structure diagram
    ACTJIL114887587-25-9 In Stock
Inquiry

2. ACTJIL114 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0 In Stock
  2. Plus
  3. ACMBNA948 route compound structure diagram
    ACMBNA948315718-06-0 In Stock
  4. Then
  5. ACTJIL114 route product structure diagram
    ACTJIL114887587-25-9 In Stock
Inquiry

Comments (0)